共 156 条
[1]
Kekre N(2019)Venous thromboembolism incidence in hematologic malignancies Blood Rev 33 24-32
[2]
Connors JM(2005)Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 715-722
[3]
Blom JW(2009)Cancer-associated venous thrombosis in the surgical setting Ann Surg 249 366-375
[4]
Doggen CJM(2023)Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery Thromb J 21 86-908
[5]
Osanto S(2022)Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer Blood 140 900-2023
[6]
Rosendaal FR(2018)Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) J Clin Oncol 36 2017-22
[7]
Behranwala KA(2017)Current practice patterns and patient persistence with anticoagulant treatments for cancer-associated thrombosis Res Pract Thromb Haemost 1 14-694
[8]
Williamson RCN(2005)Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 692-122
[9]
Kiracı ZK(2019)Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery Cochrane Database Syst Rev 8 Cd004318-759
[10]
Yalçın N(2021)Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: a systematic review and meta-analysis of the literature Thromb Res 204 114-1933